Introduction
The protooncogenic protein c-Cbl is expressed ubiquitously and becomes highly tyrosine phosphorylated in response to a wide variety of stimuli. c-Cbl has been shown to interact with a number of proteins in both tyrosine phosphorylation-dependent and -independent fashions, acting as a multivalent adaptor protein and as a negative regulator of protein tyrosine kinase (PTK)-mediated signaling (Liu and Altman, 1998; Lupher et al., 1999; Thien and Langdon, 1998) . The latter eect of c-Cbl may be dependent, at least to some extent, on its recently discovered potential as an E3 ubiquitin-protein ligase Joazeiro et al., 1999; Levkowitz et al., 1998 Levkowitz et al., , 1999 Miyake et al., 1998; Ota et al., 2000; Wang et al., 1999; Waterman et al., 1999) .
Several recent studies have implicated c-Cbl in the regulation of adhesion-related events in T cells, macrophages, and normal and transformed ®broblasts. We have shown that wild-type c-Cbl facilitates adhesion and spreading of v-Abl-transformed ®bro-blasts, while its mutants, incapable of binding to phosphatidylinositol-3' (PI-3') kinase or CrkL, exhibit no eect. The reversion of morphological transformation of v-Abl-transformed ®broblasts by wild-type cCbl correlates with the c-Cbl-induced suppression of anchorage-independent growth of these cells (Feshchenko et al., 1999) . Src-family PTK-de®cient macrophages, incapable of spreading on ®bronectin (FN), exhibit a decrease in tyrosine phosphorylation of c-Cbl and its translocation to the membrane, while treatment of wild-type macrophages with Cbl-speci®c antisense oligonucleotides blocks their spreading on FN-coated surfaces (Meng and Lowell, 1998) . In T cells, a Cbl mutant de®cient in PI-3' kinase binding inhibits CD28-induced activation of b1 integrin (Zell et al., 1998) . Furthermore, truncation of SH3 binding sequences of c-Cbl inhibits formation of actin lamellae, lamellipodia and membrane rues .
Although the mechanisms mediating the eects of cCbl on cell adhesion and morphology have not been deciphered, several ®ndings suggest that small GTPases may be involved in these eects. First, the c-Cbl binding site for PI-3' kinase, an important intermediate in signaling leading to the activation of Rho-family GTPases Parker, 1995; Reif et al., 1996) , and PI-3' kinase enzyme activity are essential for the eects of c-Cbl on cell morphology and adhesion (Feshchenko et al., 1999; Zell et al., 1998) . Second, cCbl binding sites for CrkL, an adaptor involved in the activation of Rap1 and R-Ras (Arai et al., 1999; Gotoh et al., 1995 Gotoh et al., , 1997 Ichiba et al., 1997) , are essential for an increase in adhesion of v-Abl-transformed ®bro-blasts and a decrease in their transformation potential (Feshchenko et al., 1999) . Third, c-Cbl interacts, in a tyrosine phosphorylation-dependent manner, with Vav, a Rho-family guanine nucleotide exchange factor (GEF) (Marengere et al., 1997) . Fourth, c-Cbl localizes, together with c-Crk, to submembranous actin lamellae in normal ®broblasts . Finally, the dominant-inhibitory eect of a truncated version of c-Cbl on lamellipodia formation in normal ®broblasts can be reversed by constitutively active Rac .
However, in spite of the likely importance of c-Cbl in modulating cell adhesion and morphology, the mechanisms mediating this function of c-Cbl remain poorly understood. Since we previously showed that cCbl facilitates adhesion of v-Abl-transformed ®bro-blasts (Feshchenko et al., 1999) , we were prompted to further investigate the mechanisms of these eects. In this report we demonstrate that the eect of c-Cbl on adhesion of v-Abl-transformed NIH3T3 cells is primarily mediated by an increase in FN matrix deposition by these cells. The observed increase in FN matrix deposition is dependent on c-Cbl tyrosine phosphorylation, c-Cbl-mediated activation of small GTPases, and c-Cbl-mediated ubiquitination.
Results

Effects of c-Cbl on the adhesion of v-Abl-transformed fibroblasts to an FN-coated surface
We previously showed that c-Cbl facilitates adhesion of v-Abl-transformed ®broblasts (Feshchenko et al., 1999) . However, the exact mechanism by which c-Cbl upregulates cell adhesion remained unknown. Considering the importance of interactions between cells and extracellular matrix (ECM) for cell adhesion and the lack of information on this subject for our experimental system, we decided to analyse interactions of v-Abl-transformed ®broblasts with culture surfaces pre-coated with FN or total ECM. Consistent with our previous study (Feshchenko et al., 1999) , c-Cbl upregulated adhesion of v-Abl-transformed ®broblasts in the absence of pre-coating in a manner dependent on its C-terminal tyrosine phosphorylation ( Figure 1a) . However, no dierence in adhesion between vector control, wild-type c-Cbl-expressing, and Tyr 5 -4Phe Cbl-expressing v-Abl-transformed ®broblasts was detected, when tissue culture plates were pre-coated with FN ( Figure 1a ) or total ECM (data not shown). This result argued that the dierential adhesion of v-Abltransformed ®broblasts expressing wild-type and Tyr 5 -4Phe c-Cbl, which was apparent in cell culture, was not due to the intrinsic dierences in the ability of these cells to bind to ECM, such as integrin activation.
Since cell adhesion to ECM and FN, in particular, is mediated primarily by integrins, we analysed the expression of typical integrins of ®broblasts (Herzho et al., 1999; Klein et al., 1996; Scardigli et al., 1996) on the surface of the cells studied, using¯uorescence-activated¯ow cytometry. These experiments showed that all the cell clones examined expressed the same pattern of integrins. Subunits a 1 , a v , b 3 , and b 4 were not expressed on these cells, while a 2 was expressed at a low level. In contrast, a 5 , a 6 , and b 1 subunits were highly expressed (Table 1) . Noteworthy, no dierence in the expression of the integrins studied was detected between v-Abl-transformed ®broblasts expressing wildtype or Tyr 5 -4Phe c-Cbl.
Role of integrins in c-Cbl-facilitated adhesion of v-Abl-transformed fibroblasts
The ®ndings indicating that dierences in adhesion observed in culture between v-Abl-transformed ®bro- blasts expressing wild-type and Tyr 5 -4Phe c-Cbl were not due to dierences in their abilities to bind to ECM prompted us to determine whether adhesion of the wild-type c-Cbl-expressing cells in the absence of precoating with ECM components, i.e. under conditions used in our previously reported experiments (Feshchenko et al., 1999) , was dependent on integrins. To address this issue, we added monoclonal antibodies (mAbs), blocking integrin-ligand interactions, to v-Abltransformed ®broblasts expressing wild-type c-Cbl cultured in the absence of any pre-coating of tissue culture plates. None of the single mAbs could reduce cell adhesion in this system (data not shown). Therefore, we utilized pairs of mAbs corresponding to various relevant heterodimeric integrins. Since all the cells examined expressed a 5 b 1 (FN receptor) and a 6 b 1 (laminin receptor) at high levels and a 2 b 1 (collagen receptor) at a modest level, we examined eects of the mAb pairs corresponding to these receptors and compared these eects to those of the negative control pair a v b 3 (vitronectin/FN receptor) (see Table 1 ). This analysis showed that the adhesion of v-Abl-transformed cells expressing wild-type c-Cbl was signi®-cantly reduced by the anti-a 5 /anti-b 1 mAb pair, but not by other pairs examined (Figure 1b ). This ®nding indicated that the c-Cbl-facilitated adhesion of v-Abltransformed NIH3T3 cells in culture was mediated by a 5 b 1 , the major FN receptor of ®broblasts (Akiyama, 1996; Ruoslahti, 1996) , even in the absence of FN precoating.
Effects of c-Cbl on ECM and FN deposition by v-Abl-transformed fibroblasts
Since our results showed that c-Cbl-facilitated adhesion of v-Abl-transformed ®broblasts in culture was mediated by a 5 b 1 (Figure 1b) , and no dierences were observed between v-Abl-transformed ®broblasts expressing wild-type and Tyr 5 -4Phe c-Cbl either in adhesion to an FN-coated surface, or in a 5 b 1 surface expression ( Figure 1a , (Figure 2 ). Unlike the culture plate surfaces, supernatants of c-Cbl-overexpressing v-Abl-transformed ®broblasts did not change adhesion of the indicator cells (data not shown). These data indicated that cCbl enhanced the ability of v-Abl-transformed ®broblasts to deposit ECM on the surface of the tissue culture plate.
Since the observed adhesion of c-Cbl-overexpressing v-Abl-transformed ®broblasts to ECM was primarily mediated by a 5 b 1 , the major FN receptor of ®broblasts, and since FN induced adhesion of v-Abl-transformed ®broblasts (Figure 1 ), we focused our further eorts on analysing the eects of c-Cbl on production and deposition of FN using ELISA and immunoblotting. FN-speci®c ELISA utilized to quantify FN in culture supernatants and cell lysates was based on using a capture antibody and a detection antibody in a typical sandwich protocol. For detection of FN deposited on the surfaces of tissue culture plates, we removed the cells, washed the plates and added a detection antibody to these plates. The results of ELISA experiments showed that expression of either form of c-Cbl in v- Abl-transformed ®broblasts did not aect the amount of FN in supernatants and cell lysates (data not shown). Considering that culture supernatants and the corresponding cell lysates, combined, accounted for approximately 95% of total FN in each sample (data not shown), we concluded that c-Cbl expression did not modify total FN production by v-Abl-transformed cells. However, expression of wild-type c-Cbl substantially increased the amount of FN deposited on plastic (Figure 3a) . Analysis of these samples by anti-FN immunoblotting con®rmed the results obtained by ELISA (Figure 3b) . The partial c-Cbl mutants Y731F and Y700F/Y774F, previously shown to be incapable of increasing adhesion of v-Abl-transformed ®broblasts in culture (Feshchenko et al., 1999) , were also incapable, like Tyr 5 -4Phe Cbl, of increasing FN matrix production (Figure 3a) . Taken together, these ®ndings indicated that the observed increase in adhesion of v-Abl-transformed ®broblasts expressing wild-type c-Cbl was primarily caused by an increase in FN deposition by these cells.
Effects of c-Cbl on cytoskeletal reorganizations in v-Abl-transformed fibroblasts
We previously showed that overexpression of wildtype, but not Tyr 5 -4Phe, c-Cbl in v-Abl-transformed ®broblasts dramatically facilitated formation of F-actin ®bers and focal adhesions (Feshchenko et al., 1999) . Since v-Abl-transformed ®broblasts overexpressing wild-type c-Cbl produced signi®cantly more FN matrix than did Tyr 5 -4Phe-expressing cells (see Figure 3) , it remained unclear whether the previously observed dierences were due to dierential production of FN matrix by these cells or to the intrinsic dierences in their ability to reorganize cytoskeleton. To address this issue, we plated v-Abl-transformed ®broblasts expressing various forms of c-Cbl on an FN-coated surface and analysed their morphology. Although each type of v-Abl-transformed ®broblasts became, to a substantial extent, adherent in these experiments, the majority of wild-type c-Cbl-expressing cells re-acquired the typical ®broblastoid phenotype featuring multiple focal adhesions and stress ®bers, whereas cells expressing Tyr 5 -4Phe, Y731F and Y700F/Y774F mutants and vector control cells displayed varying degrees of transformed phenotypes (Figure 4 and data not shown).
Effects of c-Cbl on the activity of Rho-family GTPases in v-Abl-transformed fibroblasts
Since the formation of F-actin ®bers and focal adhesion complexes is known to be regulated by Rho-family GTPases (reviewed in Schoenwaelder and Burridge, 1999) , the observed c-Cbl-dependent facilitation of cell spreading, actin polymerization and focal adhesions' assembly argued that wild-type c-Cbl is capable of activating Rho-family GTPases. Considering that Rho-dependent contractility was recently shown to be essential for the assembly of FN matrix by ®broblasts (Christopher et al., 1997; Wu et al., 1995; Zhang et al., 1997; Zhong et al., 1998) , we decided to determine whether an increase in spreading of v-Abltransformed ®broblasts caused by c-Cbl overexpression facilitated FN matrix deposition by these cells through the activation of small GTPases regulating cytoskeletal rearrangements. First, we directly evaluated activities of several such GTPases in v-Abl-transformed ®bro-blasts using precipitation of their GTP-bound forms followed by speci®c immunoblotting. Since our experiments showed that RhoA, Rac1 and Rap1 were expressed at a considerable level in the cells studied, while Cdc42 and R-Ras were not detectable (data not shown), we measured activities of RhoA, Rac1 and Rap1. These experiments indicated that Rac1 was signi®cantly activated in cells expressing wild-type cCbl, and less so in those expressing Tyr 5 -4Phe Cbl (Figure 5a ). They also demonstrated that c-Cblmediated activation of Rac1 was further facilitated by pervanadate (Figure 5a ), which increases tyrosine phosphorylation of c-Cbl in our experimental system (Feshchenko et al., 1999) . Furthermore, c-Cbl was capable of enhancing Rap1 activity in pervanadate- Figure 5b ). In contrast, we failed to detect any GTPbound RhoA in our experimental system in spite of using several alternative protocols and Rho-binding domains Reid et al., 1996; Ren et al., 1999; Sander et al., 1998) . Since a dramatic increase in the assembly of stress ®bers and focal adhesions, which is thought to be an indication of RhoA activity, is always seen in c-Cbl-overexpressing v-Abl-transformed ®broblasts ( Figure 4 and Feshchenko et al., 1999), we submit that the apparent lack of GTP-bound RhoA in the cell lysates is due to the abundance of Rho-speci®c GTPase activating proteins and not to the lack of intrinsic RhoA activity.
Role of Rho-family GTPases in c-Cbl-induced effects in v-Abl-transformed fibroblasts
Since our results argued that c-Cbl is capable of activating Rac1 and RhoA in v-Abl-transformed NIH3T3 cells, and since activation of these GTPases is critical for the assembly of cytoskeleton (reviewed in Schoenwaelder and Burridge, 1999) and the consequent FN matrix deposition by ®broblasts Figure 4 Morphology of v-Abl-transformed NIH3T3 cells expressing wild-type or Tyr 5 -4Phe c-Cbl on an FN-coated surface. The cells were analysed using phase-contrast microscopy in culture (top panels) or paxillin or F-actin staining followed by¯uorescence confocal microscopy (middle and bottom panels, respectively). Cells overexpressing wild-type c-Cbl (wtA4 clone, the left column) were¯at and exhibited numerous focal adhesions and stress ®bers. Cells expressing Tyr 5 -4Phe (clone mutB5, the right column) were mostly spindle-like; they had F-actin ®bers only at the edges and few focal adhesions, mostly at the edges of extensions (shown by arrowheads). The morphology of v-Abl-transformed NIH3T3 cells transduced with the control empty vector was similar to that of v-Abl-transformed NIH3T3 cells transduced to express Tyr 5 -4Phe (not shown). A representative experiment from a total of four is shown (Christopher et al., 1997; Wu et al., 1995; Zhang et al., 1997; Zhong et al., 1998) , we decided to directly analyse the involvement of these GTPases in the eects of c-Cbl in our experimental system. For these experiments we used SCH 51344, a speci®c inhibitor of Rac1-dependent signaling, and several compounds known to impede RhoA-dependent cytoskeletal reorganization; C3 exoenzyme, 3-butanedione 2-monoxime (BDM), H7 and Y27632. It has been shown that SCH 51344 speci®cally blocks Rac1-induced morphological eects (Walsh et al., 1997) . The exact target of SCH 51344 is not known, although it appears to be located in the signal transduction pathway between Rac1 and LIM kinase-1 (Kumar et al., 1999) . The C3 exoenzyme is produced by Clostridium botulinum and is capable of ADP-ribosylating the Rho proteins, but not Rac or Cdc42 proteins (Wilde et al., 2000) . The C3 exoenzyme has been shown to inhibit the Rhodependent generation of stress ®bers Ridley and Hall, 1992 ). RhoA appears to induce cytoskeletal rearrangements through the activation of the Rho-dependent kinase, referred to as ROCK or ROK, which phosphorylates and inhibits myosin phosphatase, thus elevating the level of myosin light chain phosphorylation (Feng et al., 1999; Kawano et al., 1999; Kimura et al., 1996; Parizi et al., 2000) . Y27632 is a speci®c inhibitor of ROCK (Ishizaki et al., 2000) , and therefore it is used to block Rho-induced cytoskeletal rearrangements (Feng et al., 1999; Parizi et al., 2000) . Likewise, H7 and BDM inhibit events essential for cell contractility that are thought to be regulated by Rho. H7, an inhibitor of myosin light chain kinase, has been shown to promote disassembly of stress ®bers and focal adhesions (Chrzanowska-Wodnicka and Burridge, 1996; Lamb et al., 1988; Volberg et al., 1994) . BDM, an inhibitor of actin-myosin ATPase (McKillop et al., 1994) , is also capable of blocking the Rhoinduced eects on cytoskeleton (Chrzanowska-Wodnicka and Burridge, 1996; Zhong et al., 1998) . Although these inhibitors of Rho-and Racdependent functions did not aect adhesion of either c-Cbl-overexpressing or vector control v-Abltransformed ®broblasts to an FN-coated surface (data not shown), they dramatically reduced adhesion of c-Cbl-overexpressing cells in the absence of FN pre-coating (Figure 6a ). (The eect of the inhibitors on vector control v-Abl-transformed ®bro-blasts in the absence of FN pre-coating was not studied, because the vector control and Tyr 5 -4Phe-expressing cells did not adhere to the non-coated surfaces (see Figure 1a) .) The ®nding that inhibitors of Rho and Rac signaling signi®cantly decreased the adhesion of v-Abl-transformed ®broblasts to noncoated surfaces, yet failed to perturb their adhesion to FN pre-coated surfaces, suggested that these inhibitors aect FN deposition. Direct measurements showed, indeed, that SCH 51344 and Y27632 dramatically inhibited the ability of c-Cbl-overexpressing v-Abl-transformed ®broblasts to deposit FN ( Figure 6b ).
As indicated above, Rho-dependent cytoskeletal reorganizations have been shown by several groups to be essential for FN matrix deposition by ®broblasts (Christopher et al., 1997; Wu et al., 1995; Zhang et al., 1997; Zhong et al., 1998) . This ®nding prompted us to determine whether the inhibitors that diminished deposition of FN matrix by c-Cbl-overexpressing v-Abl-transformed ®broblasts and adhesion of these cells to a non-treated surface (see Figure 6 ) could also inhibit spreading of these cells in culture. Indeed, these inhibitors dramatically aected spreading of c-Cbl-overexpressing v-Abltransformed ®broblasts. SCH 51344 caused`shrinking' of well-spread cells at low concentrations and their complete`rounding' at higher concentrations ( Figure 7 ). Y27632 caused, even at low concentrations, a collapse of¯at cells and formation of rounded' cells and cells with long neurite-like extensions, which progressed with increasing concentration of Y27632 (Figure 7) . Likewise, C3 exoenzyme caused collapse of¯at cells and formation of rounded' cells. Importantly, inhibition of Rac-and Rho-mediated signaling prevented spreading of c-Cbloverexpressing v-Abl-transformed ®broblasts regardless whether or not the tissue culture surface was precoated with FN ( Figure 7 ). Considering the crucial role of the c-Cbl binding site for the p85 subunit of PI-3' kinase in the eect of c-Cbl on cell adhesion in our experimental system (Feshchenko et al., 1999) and the results indicating that PI-3' kinase is involved in activation of Rho-family GTPases Parker, 1995; Reif et al., 1996) , we analysed the eect of PI-3' kinase on adhesion of vAbl-transformed ®broblasts and their spreading on FN-coated surfaces. v-Abl-transformed ®broblasts overexpressing wild-type c-Cbl were transfected with an expression vector encoding wild-type or dominantinhibitory p85, and their adhesion was assessed in culture without FN pre-coating. Expression of wildtype p85 signi®cantly increased the fraction of adherent v-Abl-transformed ®broblasts overexpressing wild-type c-Cbl, while a dominant-inhibitory form of p85 signi®cantly reduced it, as compared to the eect of the corresponding control vector (Figure 8a ). The levels of wild-type and dominant-inhibitory p85 expression were comparable in the transfected cells and dramatically exceeded the level of endogenous p85 expression (Figure 8a ). To assess the eect of p85 on spreading of v-Abl-transformed ®broblasts on FN matrix, wild-type c-Cbl-overexpressing v-Abl-transformed ®broblasts were co-transfected with expression vectors for p85 and enhanced green¯uorescent protein (EGFP) and then plated on an FN-coated surface. The analysis of morphology of transfected cells showed that expression of dominant-inhibitory p85 reduced their spreading on FN, while expression of wild-type p85 facilitated their spreading on FN as compared to the corresponding vector-transfected cells (Figure 8b ). The Considering the importance of Vav GEFs for the activation of Rho-like GTPases, we also analysed tyrosine phosphorylation of Vav2, a ubiquitously expressed form of Vav (Henske et al., 1995) , in control, c-Cbl-and Tyr 5 -4Phe-overexpressing v-Abl-transformed NIH3T3 cells. Tyrosine phosphorylation of Vav2 was increased both in cells expressing wild-type cCbl and in those expressing Tyr 5 -4Phe, as compared to vector control cells (data not shown). However, only wild-type c-Cbl co-immunoprecipitated with Vav2 (data not shown), consistent with previously reported data (Marengere et al., 1997) .
Since the sites of c-Cbl essential for binding of CrkL, which appears to play a role in the activation of Rap1 (Gotoh et al., 1995; Ichiba et al., 1997) , are essential for the eects of c-Cbl in our experimental system (Feshchenko et al., 1999) , and since Rap1 becomes activated in c-Cbl-overexpressing v-Abl-transformed NIH3T3 cells following pervanadate stimulation (Figure 5b) , we attempted to analyse the eect of CrkL on adhesion of these cells and their spreading on an FNcoated surface. Using the approach described for p85, we expressed wild-type CrkL and putative CrkL dominant-inhibitory forms in v-Abl-transformed ®bro-blasts overexpressing wild-type c-Cbl, and assessed adhesion of the transfected cells in culture. Expression levels of ectopic CrkL proteins were found to be comparable to each other and signi®cantly exceeded the endogenous level of CrkL (Figure 9 ). However, in contrast to the p85 mutant, none of the mutant forms Figure 7 Eects of inhibitors of RhoA-and Rac1-dependent functions on morphology of v-Abl-transformed NIH3T3 cells expressing wild-type c-Cbl. c-Cbl-overexpressing v-Abl-transformed NIH3T3 cells (clone wtA4) plated either on an FN-coated surface or without FN pre-coating as indicated were treated with C3, SCH 51344 or Y27632. The cells were treated with SCH 51344 and Y27632 at the time of their seeding. DMSO was added at a concentration of 0.2% to each culture in the experiments with SCH 51344, since this inhibitor has been dissolved in DMSO. The cells were treated with the C3 exoenzyme by scrape-loading. The concentrations of inhibitors are shown in the corresponding panels. The cells were photographed using phase-contrast microscopy 18 h after the inhibitor treatment. A representative experiment from a total of three is shown for each inhibitor of CrkL studied, R39L (SH2-de®cient), W271L (de®-cient in the C-terminal SH3), W160L/W271L (de®cient in both SH3s) or R39L/W160L/W271L (de®cient in SH2 and both SH3s), was capable of reducing cell adhesion (Figure 9 ). In spite of this failure, wild-type CrkL signi®cantly facilitated adhesion of v-Abltransformed ®broblasts (Figure 9 ), suggesting a certain role for CrkL in the observed phenomena.
Role of ubiquitination in c-Cbl-induced effects on v-Abl-transformed fibroblasts It has been recently shown that c-Cbl-dependent targeting PTKs to proteosomal degradation is mediated by the ubiquitin-protein ligase activity of cCbl Joazeiro et al., 1999; Levkowitz et al., 1998 Levkowitz et al., , 1999 Miyake et al., 1998; Ota et al., 2000; Waterman et al., 1999) . Therefore, we evaluated the role of ubiquitination in the eects of cCbl in our experimental system using two approaches.
First, we examined behavior of v-Abl-transformed ®broblasts overexpressing, in a stable manner, a ubiquitination-defective mutant of c-Cbl, C381A . These experiments demonstrated that C381A, unlike wild-type c-Cbl, could not cause adhesion of v-Abl-transformed ®broblasts to a tissue culture surface in the absence of FN pre-coating, while not hindering the ability of these cells to adhere to an FN-coated surface (Figure 10a ). This result could be explained by the observed inability of C381A to facilitate FN matrix deposition by v-Abl-transformed Figure 9 Eects of CrkL on adhesion of v-Abl-transformed NIH3T3 cells expressing wild-type c-Cbl. v-Abl-transformed NIH3T3 cells expressing wild-type c-Cbl (clone wtA4) were transfected with a control vector or vectors expressing wild-type or various putative dominant-inhibitory forms of CrkL as indicated. The cells were co-transfected with the selection vector pMACS4 and then magnetically sorted. Adhesion of the sorted cells was studied by direct cell counting, and expression of CrkL proteins in these cells was studied using anti-CrkL immunoprecipitation followed by anti-CrkL immunoblotting. For adhesion, mean values and standard errors for two independent experiments are shown. Anti-CrkL blots are shown for a representative experiment from a total of two The cells were co-transfected with selection vectors pMACS4 (a) or EGFP-C2 (b). (a) Transfected cells were selected using magnetic sorting, and their adhesion in culture without FN pre-coating was studied by direct cell counting. Expression of p85 in these cells was studied using anti-p85 immunoprecipitation followed by anti-p85 immunoblotting. For adhesion, mean values and standard errors of two independent experiments are shown. Anti-p85 blots are shown for a representative experiment from a total of two. (b) Cells cotransfected with a p85 expression plasmid and EGFP-C2 were plated, without sorting, on an FN-coated surface and photographed using¯uorescence (the left column) and phase-contrast microscopy (the right column) 48 h after transfection. Green¯uorescence was indicative of the presence of recombinant p85 in transfected cells, which are shown by arrowheads. The results of a representative experiment from a total of three are shown ®broblasts (Figure 10b ). Consistent with our ®ndings described above in this report, the inability of C381A to induce adhesion of v-Abl-transformed ®broblasts to a non-pretreated cell culture surface and to facilitate FN matrix deposition by these cells correlated with the inability of this c-Cbl mutant form to promote spreading of v-Abl-transformed ®broblasts on an FNcoated surface (Figure 10c ). Second, we assessed the eects of MG115 and MG132, speci®c proteosome inhibitors capable of blocking c-Cbl-induced protein degradation (Lee and Goldberg, 1998), on cell adhesion of c-Cbl-overexpressing v-Abl-transformed ®broblasts and FN matrix production by these cells. Consistent with the results obtained with C381A-expressing clones, both MG115 and MG132 abrogated c-Cbl-mediated adhesion of vAbl-transformed ®broblasts in the absence of FN precoating, while not inhibiting adhesion of these cells to an FN-coated surface (Figure 10d) . Together, these results indicate that c-Cbl-mediated ubiquitination is essential for the observed eects of c-Cbl in v-Abltransformed ®broblasts.
Discussion
Several recent reports have implicated c-Cbl in the regulation of adhesion-related events (Feshchenko et al., 1999; Meng and Lowell, 1998; Scaife and Langdon, 2000; Zell et al., 1998) . We have previously shown that wild-type c-Cbl facilitates adhesion and spreading of vAbl-transformed NIH3T3 cells, while its tyrosine phosphorylation-defective forms do not cause these eects (Feshchenko et al., 1999) . Considering the importance of cell-ECM interactions for cell adhesion and morphology, we have addressed, in our current studies, the role of these interactions in the observed eects of c-Cbl.
The initial experiments indicated that although the adhesion of v-Abl-transformed ®broblasts expressing wild-type c-Cbl was mediated by their major FN receptor, a 5 b 1 (Figure 1b) , v-Abl-transformed ®bro-blasts expressing wild-type and tyrosine phosphorylation-defective forms of c-Cbl did not dier in their ability to adhere to FN-or ECM-coated surfaces ( Figure 1a and data not shown). We therefore hypothesized that the observed increase in adhesion of v-Abl-transformed NIH3T3 cells expressing wildtype c-Cbl was caused by an increase in the production of ECM by these cells. This hypothesis was supported by our ®nding that v-Abl-transformed vector control cells exhibiting a non-adherent phenotype in`conventional' culture were capable of adhering to ECM deposited by c-Cbl-expressing Abl-transformed ®bro-blasts (Figure 2 ). Since adhesion of the cells studied was mediated by their major FN receptor, and since FN was able to fully mimic ECM in the induction of cell adhesion (Figure 1 and data not shown), we focused our eorts on analysing the eects of c-Cbl on FN production. Direct measurements of FN showed that overexpression of wild-type c-Cbl, but not of its tyrosine phosphorylation-defective mutants, signi®-cantly increased deposition of FN matrix by v-Abltransformed ®broblasts (Figure 3) , thus further supporting the notion that the observed c-Cblmediated increase in cell adhesion is caused by an increase in ECM deposition.
To examine the molecular basis of the c-Cblmediated increase in FN matrix deposition by v-Abl- transformed ®broblasts we chose to focus on possible functional links between c-Cbl and small GTPases involved in the regulation of cell adhesion and cytoskeletal rearrangements. Two major bodies of data pointed to the involvement of small GTPases in the observed eects of c-Cbl. First, our previous studies (Feshchenko et al., 1999) have shown that the eects of c-Cbl on adhesion of v-Abl-transformed ®broblasts are dependent on its binding sites for PI-3' kinase and CrkL, proteins involved in the activation of Rho-family GTPases and Rap1 (Gotoh et al., 1995; Ichiba et al., 1997; Parker, 1995; Reif et al., 1996) . Rho-family GTPases, RhoA, Rac1 and Cdc42, regulate assembly/disassembly of actin structures, focal adhesions and focal complexes (reviewed in Magnusson and Mosher, 1998; Schlaepfer and Hunter, 1998; Schoenwaelder and Burridge, 1999; Tapon and Hall, 1997) . Rap1 can aect cell adhesion and cytoskeletal responses (Katagiri et al., 2000; Kawata et al., 1988; Kitayama et al., 1989; Reedquist et al., 2000; Tsukamoto et al., 1999) . Second, FN matrix assembly has been shown to be dependent on cytoskeletal rearrangements regulated by Rho-family GTPases (Christopher et al., 1997; Wu et al., 1995; Zhang et al., 1997) . Furthermore, it has been shown that activation of RhoA stimulates FN matrix assembly, whereas inhibition of RhoA signaling suppresses it (Zhang et al., 1997) . The dependence of FN matrix assembly on Rho-dependent contractility can be explained by the ®nding that this contractility exposes a cryptic site of FN crucial for assembly of FN molecules into matrix (Zhong et al., 1998) . Direct measurements of GTP-bound Rac1 in v-Abltransformed ®broblasts demonstrate that the overexpression of wild-type c-Cbl activates Rac1 to a substantially higher extent than does the overexpression of Tyr 5 -4Phe Cbl (Figure 5a ). Furthermore, pervanadate treatment of v-Abl-transformed ®bro-blasts, which signi®cantly increases tyrosine phosphorylation of c-Cbl and other proteins in these cells (Feshchenko et al., 1999) , augments the stimulating eect of wild-type c-Cbl as compared to that of its tyrosine phosphorylation-defective mutant (Figure 5a ). Using the same approach based on the direct detection of GTP-bound GTPases, a somewhat similar result has been obtained for Rap1 with the exception that activation of Rap1 in wild-type c-Cbl-overexpressing v-Abl-transformed ®broblasts is only detectable in the presence of pervanadate (Figure 5b ). Although we have failed to detect GTP-bound RhoA in v-Abl-transformed ®broblasts expressing wild-type c-Cbl, the profound assembly of stress ®bers and focal adhesions, which is considered to be a result of RhoA activation (Magnusson and Mosher, 1998; Schlaepfer and Hunter, 1998; Schoenwaelder and Burridge, 1999; Tapon and Hall, 1997) , strongly argues that RhoA is activated in these cells (Figure 4 and Feshchenko et al., 1999) . The lack of stress ®bers and focal adhesions in v-Abl-transformed ®broblasts expressing Tyr 5 -4Phe shows that the tyrosine phosphorylation of c-Cbl is essential for the RhoA-dependent assembly of stress ®bers and focal adhesions. Taken together, these results indicate that RhoA, Rac1 and, possibly, Rap1 are activated in v-Abl-transformed ®broblasts overexpressing wild-type c-Cbl.
Since overexpression of c-Cbl induces in our experimental system both FN matrix deposition and activation of small GTPases involved in cytoskeletal rearrangements, and since contractility of ®broblasts, which depends on the activity of small GTPases, regulates their FN matrix deposition (Christopher et al., 1997; Wu et al., 1995; Zhang et al., 1997; Zhong et al., 1998) , we hypothesized that c-Cbl induced FN matrix deposition by v-Abl-transformed NIH3T3 cells through facilitation of Rho family-dependent stretching of these cells. To test this hypothesis we analysed the eects of speci®c inhibitors of RhoA-and Rac1-dependent signaling on cytoskeletal reorganizations, FN matrix deposition and adhesion of v-Abl-transformed ®broblasts. These experiments indicate that, in agreement with previously reported data, inhibitors of RhoA-and Rac1-dependent signaling signi®cantly reduce spreading of c-Cbl-overexpressing v-Abl-transformed ®broblasts both on a surface pre-coated with FN and in the absence of FN pre-coating, i.e. on ECM produced by the c-Cbl-overexpressing ®broblasts themselves (Figure 7) . Consistent with our hypothesis, FN matrix deposition by c-Cbl-overexpressing v-Abltransformed ®broblasts is abrogated by treatment of these cells with inhibitors of Rho-and Rac-dependent signaling (Figure 6b ). The decrease in FN matrix Figure 11 Schematic representation of the eects of c-Cbl on cell spreading, FN matrix production and cell adhesion in v-Abltransformed ®broblasts deposition caused by these inhibitors blocks the adhesion of c-Cbl-overexpressing v-Abl-transformed ®broblasts in the absence of FN pre-coating ( Figure  6a and data not shown). Consistent with the notion that the c-Cbl-dependent adhesion of these cells to a non-treated surface is caused by the induction of FN matrix deposition (Figures 1-3) , inhibition of Rho-and Rac-dependent signaling does not signi®cantly reduce their adhesion to an FN pre-coated surface.
The results of our study therefore argue that the eect of c-Cbl overexpression on v-Abl-transformed ®broblasts is based on activation of RhoA and Rac1. This activation facilitates cytoskeletal rearrangements that promote spreading of v-Abl-transformed ®bro-blasts following their initial low-strength adhesion and, hence, promote deposition of FN matrix by these cells on a tissue culture surface. This increase in FN matrix deposition further facilitates cell adhesion and FN matrix assembly (Figure 11 ). The role of Rap1 in the observed eects of c-Cbl is less certain. First of all, Rap1 is activated in c-Cbl-overexpressing v-Abltransformed ®broblasts only in the presence of pervanadate (Figure 5b) . Furthermore, none of the putative dominant-inhibitory forms of CrkL reduces the adhesion of c-Cbl-overexpressing v-Abl-transformed ®broblasts in culture (Figure 9 ), in spite of the apparent functional connection between Rap1 and CrkL (Gotoh et al., 1995; Ichiba et al., 1997) . Finally, it is impossible to evaluate the role of Rap1 in cell adhesion using speci®c inhibitors of its functions, since such inhibitors are not currently available. However, a signi®cant increase in Rap1 activity in pervanadatetreated c-Cbl-overexpressing v-Abl-transformed ®bro-blasts ( Figure 5b ) and an increase in the adhesion of these cells overexpressing wild-type CrkL (Figure 9) , together with the apparent involvement of Rap1 in cytoskeletal phenomena and adhesion, support the notion of a functional link between the observed eects of c-Cbl and Rap1 (see Figure 11) .
Considering an apparent functional connection between c-Cbl and small GTPases in our experimental system, we have studied the mechanisms mediating these interactions. Since PI-3' kinase has previously been shown to activate Rho-family GTPases Parker, 1995; Reif et al., 1996) , and since we have shown in our previous (Feshchenko et al., 1999) and current report that the eects of c-Cbl on v-Abltransformed cells require tyrosine-731, the binding site for the p85 subunit of PI-3' kinase, as well as the intact enzymatic activity of PI-3' kinase, we have further analysed the contribution of PI-3' kinase to the eects of c-Cbl in our experimental system using dominantinhibitory p85. As expected from previous results, dominant-inhibitory p85 reduces adhesion of c-Cbloverexpressing v-Abl-transformed ®broblasts in the absence of ECM pre-coating, while wild-type p85 promotes it (Figure 8a ). To determine whether this eect of p85 on cell adhesion is mediated by cell spreading, the eect of wild-type and dominantinhibitory p85 on morphology of c-Cbl-overexpressing v-Abl-transformed ®broblasts seeded on an FN-coated surface has been studied. These experiments demonstrate that overexpression of wild-type p85 signi®cantly increases the number of c-Cbl-overexpressing v-Abltransformed ®broblasts stretched on an FN-coated surface, while dominant-inhibitory p85 dramatically reduces it; most cells expressing dominant-inhibitory p85 are spindle-like or round (Figure 8b) . Therefore, the eect of PI-3' kinase on adhesion of c-Cbloverexpressing v-Abl-transformed ®broblasts correlates with its eect on spreading of these cells in full agreement with our conclusions drawn from the studies using inhibitors of RhoA-and Rac1-dependent signaling.
Overall, the eects of PI-3' kinase in our experimental system are entirely consistent with its role as a positive regulator of Rho-family GTPases; it appears that PI-3' kinase is a functional link between c-Cbl and the small GTPases that induce cytoskeletal rearrangements leading to FN matrix deposition and cell adhesion. Our results argue that similar roles may be played by Vav2 and CrkL, as well. Tyrosine phosphorylation of Vav2, a ubiquitously expressed form of Vav (Henske et al., 1995) , known to activate Rho-like GTPases in a tyrosine phosphorylationdependent manner (Schuebel et al., 1998) , is increased in both wild-type c-Cbl-and Tyr 5 -4Phe-overexpressing v-Abl-transformed NIH3T3 cells, as compared to vector control cells (data not shown). However, only wild-type c-Cbl is co-immunoprecipitated with Vav2 (data not shown), consistent with the previously shown role of tyrosine-700 of c-Cbl as the Vav-binding site for this protein (Marengere et al., 1997) . The role of CrkL in the eects of c-Cbl in our experimental system is supported by a signi®cant increase in adhesion of cCbl-overexpressing v-Abl-transformed ®broblasts transfected with a wild-type CrkL expression vector (Figure 9 ). This role is consistent with the established involvement of Crk-family proteins in Rap1 activation (Gotoh et al., 1995; Ichiba et al., 1997) and their functional interactions with RhoA in regulating cytoskeletal rearrangements (Altun-Gultekin et al., 1998) . The notion that CrkL and/or Vav2 play a role in functionally connecting c-Cbl to small GTPases in vAbl-transformed ®broblasts is in full agreement with our ®nding that c-Cbl tyrosines 700 and 774, which are known to be involved in binding of Vav and CrkL to c-Cbl (Andoniou et al., 1996; Feshchenko et al., 1999; Marengere et al., 1997) , are essential for the observed eects of c-Cbl in our experimental system. Overall, our results are consistent with the following model of the eect of c-Cbl on adhesion and morphology of v-Abl-transformed ®broblasts. Tyrosine residues 700, 731 and 774 of c-Cbl are constitutively phosphorylated by v-Abl in these cells, although upregulation of their phosphorylation by extracellular stimulation, such as integrin engagement (Ojaniemi et al., 1997) , and the involvement of PTKs other than vAbl is also possible. Tyrosine-phosphorylated c-Cbl recruits PI-3' kinase, CrkL and Vav2 to Tyr-700, -731 and -774 (Andoniou et al., 1996; Feshchenko et al., 1999; Liu et al., 1997; Marengere et al., 1997) . The recruited PI-3' kinase and Vav2 stimulate RhoA and Rac1 through the release of lipid second messengers and GEF activity, respectively (Crespo et al., 1997; Parker, 1995; Reif et al., 1996; Schuebel et al., 1998) . The activation of Rho-family GTPases facilitates cytoskeletal changes that induce spreading of v-Abl-transformed ®broblasts following their initial attachment to a tissue culture surface. cCbl-enhanced ®broblast spreading promotes FN matrix deposition as a result of stretching cell-bound FN molecules, which exposes cryptic epitopes of FN that are required for the assembly of these molecules into matrix (Zhong et al., 1998 ). An increase in FN matrix deposition, in turn, facilitates further cell adhesion and spreading, thus providing a positive feedback ( Figure  11 ). It is possible that CrkL is also involved in the observed eects of c-Cbl by linking it to Rap1 or Rhofamily GTPases; but the roles of CrkL and Rap1 in our system remain to be elucidated in more detail.
Furthermore, the results presented in this report indicate that ubiquitination is essential for the eects of c-Cbl in our experimental system (Figure 10 ). Although c-Cbl-mediated ubiquitination has been shown to downregulate protein levels and kinase activities of several PTKs Levkowitz et al., 1998 Levkowitz et al., , 1999 Miyake et al., 1998; Ota et al., 2000; Waterman et al., 1999) , there is no direct evidence that this mechanism mediates the observed eects of c-Cbl on v-Abl-transformed ®broblasts. Furthermore, the lack of detectable decrease in protein tyrosine phosphorylation or v-Abl activity in v-Abl-transformed ®broblasts (Feshchenko et al., 1999) argues against downregulation of PTKs as a mechanism by which cCbl enhances adhesion of these cells. It is more likely that c-Cbl facilitates degradation of proteins involved in the negative regulation of small GTPases or downstream signaling events leading to cytoskeletal rearrangements ( Figure 11 ). Further studies are required to elucidate the role of ubiquitination in the eects of c-Cbl in our experimental system.
To summarize, our results indicate that c-Cbl facilitates adhesion of v-Abl-transformed ®broblasts in a manner that is dependent on tyrosine phosphorylation of the C-terminal domain of c-Cbl. The increase in cell adhesion is induced by c-Cbl apparently through the activation of RhoA, Rac1 and, possibly, Rap1. This activation is likely to be caused by the tyrosine phosphorylation-dependent recruitment of PI-3' kinase, CrkL and Vav2 to c-Cbl. The activation of small GTPases in c-Cbl-overexpressing v-Abl-transformed ®broblasts leads to cytoskeletal rearrangements that promote FN matrix deposition by these cells. An increase in FN matrix deposition facilitates, in turn, further cell adhesion and spreading.
At present, it remains unclear to what extent positive regulation of cell adhesion and spreading by c-Cbl, which is evident for v-Abl-transformed ®broblasts, re¯ects biological functions of c-Cbl in other cell types. Although this topic is worth further analysis, the results obtained in our experimental system de®nitively show the ability of c-Cbl to stimulate certain small GTPases through a mechanism dependent on the tyrosine phosphorylation of its C-terminal domain. Therefore, v-Abl-transformed ®broblasts appear to be an advantageous experimental system to study biological functions of this domain of c-Cbl, which presently remain rather elusive.
Finally, the results of this report are consistent with an old, but poorly understood, observation that cancerous transformation of cells frequently leads to a decrease in their ability to generate ECM (Ruoslahti, 1999; Vaheri and Mosher, 1978) , whereas exogenous or ectopically expressed FN can suppress transformed phenotypes (Akamatsu et al., 1996; Rajaraman et al., 1983) . Therefore, v-Abltransformed ®broblasts overexpressing c-Cbl represent a useful experimental system to study these puzzling links between cell transformation and ECM production.
Materials and methods
Cells
v-Abl-transformed NIH3T3 cells expressing various forms of c-Cbl were described previously (Feshchenko et al., 1999) . Cells were grown in DMEM supplemented with 10% calf serum (Life Technologies, Grand Island, NY, USA) unless indicated otherwise.
Plasmids, mutagenesis and retroviral transduction
Mutant forms of c-Cbl were generated as described previously . The C381A mutant cCbl cDNA Waterman et al., 1999) was kindly provided by Dr Y Yarden (Weizmann Institute, Rehovot, Israel). To generate new stable cell lines, cDNAs were ligated into the MSCVpac vector, and the constructs obtained were used for retroviral transduction as described previously (Merlo et al., 1998) . Cell clones were obtained by limiting dilution of puromycin-resistant cultures, expanded and tested for the expression of Cbl proteins. The pEF vectors expressing hemagglutinin (HA)-tagged wild-type and SH2-deleted dominant-inhibitory p85, a subunit of PI-3' kinase, were kindly provided by Dr T Mustelin (Burnham Institute, La Jolla, CA, USA) (Jascur et al., 1997; Von Willebrand et al., 1996) . The pGEX2T vector containing wild-type human CrkL cDNA was kindly provided by Dr B Mayer (Howard Hughes Medical Institute, Children's Hospital, Boston, MA, USA) (Tanaka et al., 1995) . For mutagenesis the wild-type CrkL cDNA was cloned into the pAlterMax vector (Promega, Madison, WI, USA). The pAlterMax CrkL R39L, pAlterMax CrkL W271L, pAlterMax CrkL W160L/W271L and pAlterMax CrkL R39L/W160L/W271L mutants were generated by sitedirected mutagenesis of the pAlterMax wild-type CrkL construct using the Altered Sites-II system (Promega) as speci®ed by the manufacturer. The mutagenic oligonucleotides were: 5'-GGAAGAATCGAGGACGAG-3' (R39L); 5'-CGGGCACTCAACCACTGT-3' (W160L); 5'-TTCGCCTTCCAACTGGCCAT-3' (W271L). All constructs were veri®ed by DNA sequencing. The pGEX2T vectors expressing glutathione-S-transferase (GST)-fused binding domains (BDs) of PAK1 (Bokoch et al., 1996; Sander et al., 1998) , PKN2 , RalGDS (Franke et al., 1997; Reedquist and Bos, 1998; Reedquist et al., 2000) and rhotekin (Reid et al., 1996; Ren et al., 1999; Sander et al., 1998) were kindly provided by Drs J Cherno (Fox Chase Cancer Center, Philadelphia, PA, USA) (PAK1), L Quilliam (Indiana University, Indianapolis, IN, USA) (PKN2), J Bos and K Reedquist (Utrecht University, Utrecht, The Netherlands) (RalGDS), J Collard (The Netherlands Cancer Institute, Amsterdam, The Netherlands) (rhotekin) and M Schwartz (The Scripps Research Institute, La Jolla, CA, USA) (rhotekin). pMACS4 plasmid encoding truncated human CD4 was purchased from Miltenyi Biotec (Auburn, CA, USA). EGFP-C2 vector expressing enhanced green uorescent protein was purchased from Clontech (Palo Alto, CA, USA).
Antibodies and recombinant proteins
The anity-puri®ed polyclonal antibodies to c-Cbl (C-15), Rap1 (121), R-Ras (C-19), Cdc42 (C-20), and CrkL (C-20), and mAbs to RhoA (26C4) and phosphotyrosine (PY20) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The rabbit polyclonal antiserum to the p85 subunit of PI-3' kinase was purchased from UBI (Lake Placid, NY, USA). Mouse mAbs to paxillin and Rac1 and the anity-puri®ed polyclonal antibody to Vav were purchased from Transduction Laboratories (Lexington, KY, USA). The rabbit anti-human FN antibody was purchased from Sigma (St. Louis, MO, USA). Rabbit antisera to HA were raised to GST-fused trimeric HA. The cDNA encoding GST-fused triple HA was kindly provided by Dr W Langdon (University of Western Australia, Nedlands, Australia). GSTfusion proteins were produced and puri®ed as described earlier (Tsygankov et al., 1994) . Staining for integrins was performed using mAbs to a 1 (Ha31/8), a 2 (Hal/29), a 5 (5H10-27), a v (H9.2B8), a 6 (GoH3), b 1 (HMb1-1), b 3 (2C9.G2), and b 4 (346-11A), and isotype controls purchased from Pharmingen (San Diego, CA, USA) followed by FITC-labeled goat anti-mouse, anti-rat or anti-hamster IgG (Cappel, Durham, NC, USA) as described previously (Tsygankov et al., 1992) . Fluorescence-activated¯ow cytometry was carried out using an EPICS system (Coulter, Fullerton, CA, USA).
Immunoprecipitation and immunoblotting
Immunoprecipitation and immunoblotting were described previously (Feshchenko et al., , 1999 Tsygankov et al., 1994 Tsygankov et al., , 1996 . Brie¯y, cell lysates were cleared by centrifugation and incubated with appropriate antibodies. Normal sera or isotype-matched IgG was used as a speci®city control. This was followed by incubation with suspension of Pansorbin (Calbiochem, La Jolla, CA, USA), which was precoated with rabbit anti-mouse IgG when mouse antibodies were used for immunoprecipitation. Immunoprecipitates were extensively washed, and their proteins were then separated by SDS ± PAGE, transferred to nitrocellulose and incubated with appropriate antibodies.
Activation assays for small GTPases v-Abl-transformed NIH3T3 cells were serum-starved for 2 ± 3 days in DMEM and activated with pervanadate for 5 min as described earlier (Feshchenko et al., , 1999 where indicated. To measure Rac1 activity cells were lysed in buer A containing 50 mM Tris, 200 mM NaCl, 10 mM MgCl 2 , 10% glycerol, 1% Nonidet P-40, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 10 mM NaF and 1 mM sodium orthovanadate at pH 7.5 for 15 min on ice. Lysates were clari®ed by centrifugation at 14 000 g for 8 min at 48C. Equal amounts of cellular protein (approximately 4 mg per sample) were immediately subjected to precipitation with 30 ± 40 mg of recombinant GST-PAK1-BD coupled to glutathione-agarose beads for 1 h at 48C. To measure Rap1 activity, cells were lysed in buer B containing 50 mM Tris, 150 mM NaCl, 0.5% sodium deoxycholate, 1% Nonidet P-40, 0.1% SDS, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 1 mM PMSF, 10 mM NaF and 1 mM sodium orthovanadate at pH 8.0 for 15 min on ice. GST-RalGDS-BD was added directly to buer B at a ®nal concentration of 100 ± 150 mg/ml. To measure RhoA activity, cells were lysed for 15 min on ice in one of several dierent buers, depending on the nature of a Rho-binding reagent. When GST-PKN2-BD was used, cells were lysed in either buer A or buer B. When GST-rhotekin-BD reagents obtained from Dr Collard and Dr Schwartz were used, cells were lysed in either buer A or buer C. The latter contained 50 mM Tris, 500 mM NaCl, 0.5% sodium deoxycholate, 1% Triton X-100, 0.1% SDS, 10 mM MgCl 2 , 10 mg/ml aprotinin, 10 mg/ml leupeptin, 1 mM PMSF, 10 mM NaF and 1 mM sodium orthovanadate. Each rhotekin-based reagent was used in conjunction with both lysis buers A and C. Each Rho-binding reagent was used in two alternative manners, namely, coupled to glutathione-agarose beads (30 ± 40 mg/ sample) or added directly to lysis buer at a ®nal concentration of 100 ± 150 mg/ml. When binding reagents were added directly to lysis buer, GTP-loaded Rap1 and RhoA were precipitated by adding 100 ml of 50% slurry of glutathione-agarose beads (Sigma) to each sample for 1 h.
Glutathione-agarose beads precipitating Rac1, Rap1 or RhoA complexes were washed three times with the corresponding lysis buer. The precipitated proteins were then eluted with SDS ± PAGE sample buer, separated using 15% SDS ± PAGE, and probed with appropriate antibodies. Blots were washed, visualized using an ECL Plus chemiluminescence kit (Pharmacia Amersham, Piscataway, NJ, USA), and quanti®ed using an Astra 1220S Scanner (UMAX, Fremont, CA, USA) and the NIH Image software.
Cell adhesion and morphology
Phase-contrast and¯uorescence microscopy in culture was performed using a CK40 microscope with a DP10 digital camera (Olympus). For confocal microscopy, performed using LSM 410 (Carl Zeiss) and IX70 (Olympus) systems, cells were grown on glass coverslips to 40% con¯uency or seeded on FN-precoated coverslips and stained using antiCbl, and either anti-paxillin or phalloidin as described previously (Feshchenko et al., 1999) . Digital images were manipulated using Adobe Photoshop 5.0 (Adobe Systems, San Jose, CA, USA). Cell adhesion was evaluated by counting adherent and suspension cells 24 h after plating as described previously (Feshchenko et al., 1999) . Total ECM from Engelbreth Holm-Swarm mouse sarcoma (Sigma) and plasma FN (Life Technologies) were added to the wells at concentrations of 20 mg/ml for 16 h at 48C. Eects of inhibitors on cell adhesion and morphology were studied by adding SCH 51344 (kindly provided by Dr CC Kumar, Schering-Plough Institute, Kenilworth, NJ, USA), Y27632 (kindly provided by Wel®de Corp., Osaka, Japan), MG115, MG132 (both from Alexis, San Diego, CA, USA), BDM or H7 (both from Sigma) at the time of seeding. Treatment with the C3 exoenzyme (Alexis) at a concentration of 10 mg/ml was carried out using scrape-loading of adherent cells as described (Malcolm et al., 1996) .
Fibronectin ELISA
To measure the amount of FN deposited as matrix, the cells were grown in 24-well plates for 72 h and then removed by incubating with 5 mM EDTA in PBS for 30 min at 378C. Rabbit anti-FN antibody was added to the PBS-washed wells at a 1 : 1000 dilution for 1 h at room temperature. The wells were then washed with PBS, and alkaline phosphataseconjugated goat anti-rabbit IgG (Cappel) was added at a 1 : 1000 dilution for 1 h at room temperature. The wells were washed with PBS, and p-nitrophenyl phosphate was added at a concentration of 2 mg/ml. Absorbance of p-nitrophenol was measured using a V max Kinetic Microplate Reader (Molecular Devices, Sunnyvale, CA, USA). The absorbance values were compared to the standard curve generated by adding FN to the same plate at de®ned concentrations, and the amount of FN in the cell-generated matrix was presented as the amount of FN that had to be added to a well to yield the corresponding p-nitrophenol absorbance. Therefore, the amounts of matrix FN in the wells are shown as concentrations in mg/ml.
FN in supernatants and cell lysates was measured using sandwich ELISA. A mouse mAb to human FN (Sigma) was immobilized on an ELISA plate at a concentration 3 mg/ml at 48C overnight. Samples and FN standards were incubated with the immobilized anti-FN mAb at 378C for 1 h, and the wells were washed with PBS. Polyclonal rabbit anti-human FN IgG (Sigma) was added at a dilution of 1 : 1000 at room temperature, and the follow-up steps were identical to those for matrix FN.
Transfection and selection of cells
Plasmid DNAs were transfected (20 mg per 1610 7 cells) using LipofectAmine 2000 (Life Technologies) following the manufacturer's recommendations. For magnetic selection, 1610 7 cells were co-transfected with 20 mg of an expression plasmid and 10 mg of pMACS4.1 selection vector. Transfectants were selected using a MACSelect4 Kit (Miltenyi Biotec) and utilized to determine protein expression and cell adhesion. To study cell morphology on an FN-coated surface, cells were co-transfected as described above with 20 mg of an expression or control plasmid and 10 mg of EGFP-C2 vector (Clontech) and then plated without sorting. Cells positive and negative for EGFP were distinguished microscopically.
Abbreviations
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